OTC Growth Will Not Find A Friend In Europe’s Financial Upheaval
This article was originally published in The Tan Sheet
Executive Summary
As economic conditions tighten in Europe, former Pfizer exec Cavan Redmond expects consumers will spend less on OTCs while increasing their scrutiny of products and prices. Difficult economic conditions sharpen the constant necessity for OTC firms generate growth, he says.